client_transactions

SSG Client Transactions

Title

Coram, Inc.
Client Profile

Client Profile

Coram Healthcare Corporation, ("Corma" or the "Company"), a publicly-traded company, is the country's largest provider of home infusion therapy products and services with revenue in excess of $400 million.
Situation

Situation

After two plans of reorganization were rejected by the Bankruptcy Court, SSG was retained to provide various valuation services and to facilitate the Company's emergence from bankruptcy through a sale or restructuring.
Solution

Solution

To date, valuation services have included: enterprise valuation for the purposes of calculating the impairment of goodwill in order to comply with FAS 142; valuation to calculate the exchange of Senior Notes to Series B; preferred stock in order for the Debtor to comply with the regulatory requirements of Stark II; preferred stock valuation. SSG also provided expert testimony in Bankruptcy Court related to the aforementioned valuations.
December 2004
Restructuring under a Plan of Reorganization
in the U.S. Bankruptcy Court for the
District of Delaware.
The undersigned acted as Investment Banker to Coram, Inc. on this transaction.

Call to learn more

Call to learn more

If you would like to learn more about this transaction, or any of our transactions, call us today.

Philadelphia
(610) 940-1094

Contact by E-mail »

New York
(212) 782-3755

Contact by E-mail »